MGZ Medizinisch Genetisches Zentrum

Spinocerebellar Ataxia Type 2, SCA2 - ATX2

Spinocerebellar ataxia type 2, SCA 2

Klinische Symptomatik

Spinocerebellar ataxias of different types show similar clinical features and are therefore not or hardly distinguishable on clinical grounds. The SCAs typically manifest in adulthood and are clinically characterized by cerebellar gait and limb ataxia, dysarthria and oculomotor disturbances, muscular hypotonia, dysdiadochokinesia, intentional tremor, and extrapyramidal symptoms. Pyramidal signs, participation of the peripheral nervous system (polyneuropathy) and autonomous systems (imperative micturition, impotence, orthostatic dysregulation) may occur (see also Information on SCA1 and SCA3).

Genetik

The SCA subtype 2 (chromosome 12q24) is inherited in an autosomal dominant manner and caused by expanded CAG repeats of the SCA gene locus.
An increasing repeat number is statistically associated with an earlier disease onset and more severe symptoms. However, an individual prognosis due to the repeat number is not possible. In SCA2, transmission of the repeat from mother to child usually is stable, in paternal transmission however a repeat expansion with earlier onset of symptoms in the child (anticipation) may occur.

 

  Repeats
normal allele  < 32
patholigical allele, reduced penetrance
32 - 33
pathological allele
≥ 32

 

Diagnostik

 

Indikation

Symptoms of cerebellar ataxia

Predictive diagnostics in persons at risk in affected families

Prenatal diagnostics in known carriers

Methodik

Normal and expanded CAG repeats are detected by PCR and subsequent fragment length analysis.

Material

2 - 4 ml of EDTA blood

Dauer

approx. 2 weeks

Versand

Mail at room temperature or laboratory courier

Beratung

For genetic counselling please call ++49-89-3090 886-0





MGZ
Medizinisch Genetisches Zentrum

Bayerstraße 3-5 (durch die Mathäser-Passage)

Eingang Schlosserstraße 6
80335 München
info@mgz-muenchen.de
Tel. +49 (0)89/30 90 886-0
Fax +49 (0)89/30 90 886-66

Ärztliche Leitung
Prof. Dr. med. Dipl. chem. Elke Holinski-Feder